Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.36), $0.08 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.